(Q44709390)

5 December 2017

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India (English)

1 reference

5 December 2017

1 reference

visceral leishmaniasis

1 reference

1 reference

3

Shyam Sundar

1 reference

5 December 2017

8

Juntra Karbwang

1 reference

5 December 2017

Sujit K Bhattacharya

1

1 reference

5 December 2017

T K Jha

2

1 reference

5 December 2017

C P Thakur

4

1 reference

5 December 2017

Juergen Engel

5

1 reference

5 December 2017

Herbert Sindermann

6

1 reference

5 December 2017

Klaus Junge

7

1 reference

5 December 2017

Anthony D M Bryceson

9

1 reference

5 December 2017

Jonathan D Berman

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

18 December 2003

1 reference

Clinical Infectious Diseases

5 December 2017

1 reference

5 December 2017

38

1 reference

5 December 2017

217-221

1 reference

5 December 2017

2

1 reference

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

5 December 2017

1 reference

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India

21 January 2018

1 reference

Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice

21 January 2018

1 reference

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis

21 January 2018

1 reference

An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population

21 January 2018

1 reference

Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study

21 January 2018

1 reference

A policy for leishmaniasis with respect to the prevention and control of drug resistance

21 January 2018

1 reference

Oral treatment of visceral leishmaniasis with miltefosine

21 January 2018

1 reference

Short-course of oral miltefosine for treatment of visceral leishmaniasis

21 January 2018

1 reference

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

21 January 2018

1 reference

Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India

21 January 2018

1 reference

Visceral Leishmaniasis and HIV Coinfection in Bihar, India

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/380638

1 reference

5 December 2017

1 reference